MPM ONCOLOGY INNOVATIONS FUND LP — Form D/A
MPM ONCOLOGY INNOVATIONS FUND LP of CAMBRIDGE, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2019-07-01. The offering totals $200.0M, of which $52.7M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-07-01
- Form: D/A
- Accession: 0001567619-19-014141
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.7
- Total offering: $200.0M
- Amount sold: $52.7M
- Remaining: $147.3M
- Investors: 31
- Date of first sale: 2018-07-12
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-315855
Issuer
- Name: MPM ONCOLOGY INNOVATIONS FUND LP
- CIK: 0001719960
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 450 KENDALL STREET, CAMBRIDGE, MA, 02142
- Phone: 617-425-9200
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ansbert Gadicke | Executive Officer | Morristown, NJ |
| Ansbert Gadicke | Promoter | Morristown, NJ |
| Luke Evnin | Executive Officer | Watertown, MA |
| Luke Evnin | Promoter | Watertown, MA |
| N/A MPM Oncology Innovations Fund GP LLC | Executive Officer | Cambridge, MA |
| N/A MPM Oncology Innovations Fund GP LLC | Promoter | Cambridge, MA |
Other filings by this issuer (2)
More